STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13D] Regional Health Properties, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D

Rhea-AI Filing Summary

Robert M. Thornton, Jr. filed a Schedule 13D reporting beneficial ownership of 269,060 shares of Regional Health Properties, Inc. (RHE), equal to 6.94% of 3,834,846 outstanding common shares as of August 19, 2025. His ownership includes 100,000 shares held directly, 125,663 held by CareVest Capital, LLC (of which he is the 100% owner), 1,133 held in an IRA, and common-equivalent shares underlying Series D Preferred Stock (41,887 via CareVest and 377 via IRA). Holdings arose from the Merger with SunLink, where SunLink shares were converted into common stock and Series D Preferred Stock. Thornton is EVP - Corporate Strategy and received a 100,000-share restricted stock award vesting in equal installments over three years. The Series D Preferred Stock carries a $12.50 liquidation preference, an 8% dividend and an initial conversion ratio of 1.1330 common shares per three preferred shares. Thornton discloses no current plans to effect extraordinary corporate actions.

Positive

  • Insider alignment: Thornton received a 100,000-share restricted stock award vesting over three years, aligning his interests with shareholders
  • Significant stake: Beneficial ownership of 269,060 shares (6.94%) signals meaningful insider investment and engagement
  • Clear disclosure: Filing details the Merger consideration and the composition of holdings, improving transparency

Negative

  • Senior preferred terms: Series D carries a $12.50 liquidation preference and 8% dividends, which rank ahead of common equity on payouts
  • Potential dilution: Series D conversion mechanics (initial 1.1330 common shares per three preferred) could dilute common shareholders if conversion occurs
  • Concentration of control: Thornton is the 100% owner of CareVest, which holds a material portion of his reported position, concentrating voting influence

Insights

TL;DR: Insider now owns 6.94% via multiple instruments; merger consideration and restricted stock increase alignment but also potential dilution.

Mr. Thornton’s 6.94% stake is sizable for an insider at this capitalization level and combines direct common shares, IRA holdings and convertible preferred-linked equivalents, which can be converted into common shares under defined triggers. The restricted stock award of 100,000 shares vests over three years, aligning his compensation with shareholder outcomes. The Series D Preferred Stock introduces a $12.50 liquidation preference and an 8% dividend that rank ahead of common equity on distributions, and its conversion mechanics (initially 1.1330 shares per three preferred) create potential future dilution if conversion conditions are met.

TL;DR: Insider role plus equity stake and time‑vested award increase governance influence but no immediate takeover intent disclosed.

As EVP - Corporate Strategy and 100% owner of CareVest, Thornton holds both executive authority and a notable equity position, which may enhance his influence on strategic decisions. The filing explicitly states there are no present plans for extraordinary transactions or board changes. The combination of employment agreement, restricted stock award, and convertible preferred exposure is a common structure to retain executive leadership following a merger; the Schedule 13D appropriately discloses these arrangements and potential paths to additional purchases or dispositions subject to applicable law and issuer policy.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
Rows 7, 9 and 11: Includes (i) 100,000 shares of Regional Health Properties, Inc. (the Issuer) common stock, no par value per share (the Common Stock) held directly by Robert M. Thornton, Jr., (ii) 125,663 shares of Common Stock, held by CareVest Capital, LLC (CareVest), (iii) 1,133 shares of Common Stock held by Mr. Thornton through an IRA, (iv) 41,887 shares of Common Stock underlying shares of the Issuer's Series D 8% Cumulative Redeemable Participating Preferred Stock, no par value per share (the Series D Preferred Stock), held by CareVest Capital, LLC (CareVest), and (v) 377 shares of Common Stock underlying shares of Series D Preferred Stock held by Robert M. Thornton, Jr. through an IRA. Mr. Thornton owns one hundred percent (100%) of the outstanding voting shares of CareVest and is the sole beneficial owner of CareVest. The Series D Preferred Stock is convertible into shares of Common Stock at the conversion ratio at the option of a holder of the Series D Preferred Stock and mandatorily upon certain events. The initial conversion ratio is 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's Amended and Restated Articles of Incorporation, as amended. Row 13: Based on 3,834,846 shares of the Issuer's common stock outstanding as of August 19, 2025, based upon the Issuer's company records. Beneficial ownership is determined in accordance with the rules of the Securities and Exchange Commission (the SEC), which deem a person to beneficially own any shares of the Issuer's Common Stock the person has or shares voting or dispositive power over and any additional shares of the Issuer's Common Stock obtainable within 60 days through the conversion or exercise of preferred stock, options or other purchase rights. Shares of the Issuer's Common Stock subject to preferred stock, options or other purchase rights that are currently exercisable or are exercisable within 60 days of August 14, 2025 (including shares subject to restrictions that lapse within 60 days of August 14, 2025) are deemed outstanding for purposes of computing the percentage ownership of the person holding such preferred stock, options or other purchase rights, but are not deemed outstanding for purposes of computing the percentage ownership of any other person.


SCHEDULE 13D


Robert M. Thornton, Jr.
Signature:/s/ Robert M. Thornton, Jr.
Name/Title:Robert M. Thornton, Jr.
Date:08/21/2025

FAQ

How many shares of RHE does Robert M. Thornton, Jr. beneficially own?

Robert M. Thornton, Jr. beneficially owns 269,060 shares, representing 6.94% of the company's common stock based on 3,834,846 shares outstanding.

What instruments make up Thornton's 269,060-share position?

The position includes 100,000 shares held directly, 125,663 shares held by CareVest Capital, LLC, 1,133 shares in an IRA, and 41,887 and 377 common-equivalents underlying Series D Preferred Stock held by CareVest and Thornton's IRA, respectively.

What are the key terms of the Series D Preferred Stock disclosed in the filing?

Series D has a $12.50 liquidation preference per share, an 8% annual dividend, and an initial conversion ratio of 1.1330 common shares per three preferred shares, subject to adjustment and mandatory conversion triggers.

How were Thornton's holdings acquired?

Holdings arose from the Merger of SunLink into Regional Health Properties, where SunLink shares were converted into Regional common stock and Series D Preferred Stock as merger consideration.

Does Thornton plan any immediate corporate actions or transactions?

The filing states Thornton has no present plans or proposals
Regional Health

NYSE:RHE

RHE Rankings

RHE Latest News

RHE Latest SEC Filings

RHE Stock Data

5.04M
1.61M
General Medical and Surgical Hospitals
Lessors of Real Property, Nec
Link
US
ATLANTA